
Optimizing drug therapies to accelerate elimination of lymphatic filariasis and onchocerciasis @WUSTLmed
St Louis, MO
Joined June 2018
- Tweets318
- Following292
- Followers222
- Likes525
DOLF retweeted
Congratulations to @DOLF_Project on 15 years of research to eliminate river blindness and lymphatic filariasis! #beatNTDs #StampOutOncho #EliminateLF dolfproject.wustl.edu/
Join the WashU Global Health Center April 30th-May 1st for two days of inspiring plenaries, panels, and networking opportunities. Learn from experts in the field and gain insights into the impact of global health research conducted @WashUpubhealth
Info> l8r.it/FHq2
Replying to @DOLF_Project
@DOLF_Project PI, Dr. Peter Fischer, and associate director Laura Peer traveled to Liberia in October for a mid-trial visit the site of DOLF’s clinical trial of treatment for the neglected tropical disease onchocerciasis (known as “river blindness”).
> l8r.it/56ky
DOLF retweeted
L’équipe de recherche clinique du @CSRS_CIV constituée du Prof Koudou Benjamin, du Dr Ouattara ALLASSANE et de Mlle Yao Laurence et @DOLF_Project, ont organisé un atelier de dissémination des résultats de l'essai clinique sur le moxidectine pour la Filariose Lymphatique.
In an effort to eradicate lymphatic filariasis, a parasitic roundworm infection spread by mosquitoes, @washumedicine scientists have developed a new genomic-based approach.
Learn about the efforts co-led by Makedonka Mitreva, PhD, @WashUID @DOLF_Project> l8r.it/tTOR
DOLF retweeted
Drs Frederic Risch, Alexander Kazakov, Sabine Specht, Kenneth Pfarr @PeterUFischer1 @HoeraufProf & Marc Hübner review the long & winding road towards new treatments against #lymphatic #filariasis & #onchocerciasis. @DZIF_ @DNDi @WUSTLmed #Helminth #Filaria
cell.com/trends/parasitology…
. @DOLF_Project investigators are beginning a follow-up study on the efficacy of a new combination treatment for lymphatic filariasis (LF) and onchocerciasis in the Akoupé district of Côte d’Ivoire.
Learn more > l8r.it/nAWB
DOLF retweeted
Exciting new work, recrudescence vs. reinfection in LF, and estimating adult worm burden by genetic profiling of the offspring! @eBioMedicine @DOLF_Project
Distinguishing recrudescence from reinfection in lymphatic filariasis
sciencedirect.com/science/ar…
Offering our congratulations to Gary Weil, MD, who has been named the inaugural Gerald and Judith Medoff Professor of Infectious Diseases at @WUSTLmed @WashUID @WUSM_MolMicro @Dolf_Project
Learn more > l8r.it/giuN
Researchers @DOLF_Project initiate a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of new combination treatments with a reference treatment of albendazole plus ivermectin. @WUSTLmed
More> l8r.it/dxUb
DOLF retweeted
We can #BeatNTDs. That’s why we are joining with global leaders and partners to eliminate two NTDs in 39 countries across Africa and Yemen 🌍
When we invest in #NTDs, we strengthen health systems, reduce poverty, and change lives. gates.ly/3NcwUf4
#RLMForum2023
DOLF retweeted
Retiring after the day's work at #Bongs Mine, Liberia. Study site @DOLF_Project #clinicaltrials for onchocerciasis. It is a pleasant reminder of how the journey all started. #RCT #beatNTDs #GONE
Gary Weil, MD @DOLF_Project Co-Founder and Director received the esteemed Kyelem Prize.
@COR_NTD is a community of researchers, program implementers and country partners with the shared goal of optimizing NTD control and elimination. @WUSTLmed
l8r.it/1eBX
DOLF retweeted
Tackling Lymphatic Filariasis can be much more challenging than tackling other vector-borne diseases. #NTDFreeIndia
@BMGFIndia @MoHFW_INDIA @nvbdcpmohfw @PCI_India_ @CHAI_health @CFARngo @PiramalFdn
As is tradition at the closing plenary of @COR_NTD, we celebrate special contributions in the fight to #beatNTDs with the presentation of the Kyelem Prize, in memory of Dominique Kyelem. Congratulations Gary Weil! #CORNTD10Years #CORNTD2023 #beatNTDs @gatesfoundation @USAIDGH
DOLF retweeted
ICYMI, the Mwele Malecela Mentorship Programme for Women in NTDs was announced at #TropMed22 by Dr. Matshidiso Moeti, Regional Director of the WHO Regional Office for Africa. Applications will open in December. youtube.com/watch?v=nsrmjaux…
DOLF retweeted
Fantastic to see Chris King @cwru awarded @ASTMH Donald Mackay for his profound & prolonged contribution to Global Health #TropMed19
DOLF retweeted
Congratulations to Yemen for undertaking excellent efforts to successfully eliminate #Filariasis as a public health problem #beatNTDs @WHOYemen @WHO
Lymphatic Filariasis was a public health problem in #Yemen in 2000 & threatened almost 120K people since then. In 2019, it was officially announced eliminated in Yemen thanks to Global Programme to Eliminate Lymphatic Filariasis, local health authorities, @AulasGSK @MectizanMDP
DOLF retweeted
'India's success in fighting infectious diseases including #Filariasis will determine whether new drugs, diagnostics and other prevention tools can be deployed effectively and affordably at scale for their elimination' - @trevormundel @gatesfoundation
https://xitter.gq/t.co/ckdI5drhjW






























